1. FLUDARA 50 mg prašek za raztopino za injiciranje ali infundiranje

FLUDARA 50 mg prašek za raztopino za injiciranje ali infundiranje

Fludarabin

General information

Drug nameFLUDARA 50 mg prašek za raztopino za injiciranje ali infundiranje
Medicine nameFludarabin
National drug code3000007
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug groupChemical Medicinal Product
OriginatorNo
Orphan drugNo

Marketing authorization

Procedure typePrenehanje veljavnosti dovoljenja za promet
No. and date of decision/certificate103-190/2018-4, 17. 11. 2019
Authorization validity date17. 11. 2019
Marketing end date17. 11. 2019
Application type—
Authorization/certificate holderGENZYME EUROPE B.V.

Drug safety monitoring

Additional safety monitoringNo
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No

ATC codes

LANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01ANTINEOPLASTIC AGENTS
L01BAntimetabolites
L01BBPurine analogues
L01BB05fludarabine

Route of administration

Route of administration name
Intravenska uporaba

Settlement data for compulsory health insurance billing

Substitute medicine

Preparation—
Valid from – to—

Clinical use data

Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo

Shortage actions

Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo

Drug status

Permanent cessation of marketing of the medicinal product.

Last drug update date:9. 7. 2026
TEST APPLICATION